News
US President Trump has taken aim at Europe for undercharging for medicine. But raising prices in Europe would face strong ...
Keep updated, follow The Business Standard's Google news channel Bangladesh's pharmaceutical industry is rapidly growing, meeting 98% of local demand and expanding its global footprint. However, ...
Reserve your free spot now. As the drug industry is in the middle of a growing policy maelstrom in Washington, D.C., investors are closely watching pharmaceutical ETFs to measure market sentiment ...
Its smart contracts are being thoroughly audited by CertiK, one of the most respected blockchain security firms in the industry ... users can use assets such as ETH and DAI to gain yield without ...
For pharma, an industry in which gross margins are among the highest in the S&P 500, labor was never really the reason for moving offshore to places like Ireland—it was always about playing the ...
The product allows investors to add CRO exposure to their portfolios without handling crypto wallets or exchanges.
It will also be a major player in the tokenization industry. ETH price has formed a small bullish flag pattern on the daily chart, pointing to an eventual rebound to $2,135, the lowest level in August ...
In this article, Christopher Ehinger questions whether rare diseases are a viable option for the pharma industry. He looks at the total number of approvals and orphan drug designations in the US ...
When President Trump signed an executive order this month to try to reduce drug prices, the pharmaceutical industry scored a big win. Within 90 days, the order said, Trump’s staff should put ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results